Suven Pharma to engage with investors in March

** Suven Pharmaceuticals (BSE: SUVENPHAR) announced that its management will be attending the Centrum CDMO Conference virtually on March 11, 2025, and the Macquarie Healthcare Tour in Hyderabad on March 12, 2025. These engagements, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, will provide opportunities for discussions with analysts and institutional investors. The company clarified that no unpublished price-sensitive information will be shared during these interactions. Suven Pharmaceuticals noted that the schedule of these meetings is subject to change based on unforeseen circumstances affecting either the analysts, institutional investors or the company.